G9412 HCPCS Level II code: Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
G9412 is the HCPCS code for “Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G9412Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
Short description: Admit w/in 180d req surg rev
HCPCS · United States
Medicare details
The indicators CMS publishes with G9412 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2015
Where G9412 sits
- 1G codesProcedures and professional services
- 2Active code G9412Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G9412 mean?
G9412 is the HCPCS code for “Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G9412?
CMS lists G9412’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9412
All G codesG9406Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient…G9407Patient did not receive follow-up within 7 days after dischargeG9408Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 daysG9409Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 daysG9410Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revisionG9411Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revisionG9413Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revisionG9414Patient had one dose of meningococcal vaccine (serogroups a, c, w, y or a, c, w, y, b) on or between the patient's 10th and 13th birthdaysG9415Patient did not have one dose of meningococcal vaccine (serogroups a, c, w, y or a, c, w, y, b), on or between the patient's 10th and 13th birthdaysG9416Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdaysG9417Patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdaysG9418Primary non-small cell lung cancer lung biopsy and cytology specimen report documents classification into specific histologic type following iaslc guidance or classified as…